Cefprozil and Interstitial nephritis - a phase IV clinical study of FDA data

Summary:

Interstitial nephritis is reported as a side effect among people who take Cefprozil (cefprozil), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Nexium, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Interstitial nephritis when taking Cefprozil. It is created by eHealthMe based on reports of 1,051 people who have side effects when taking Cefprozil from the FDA, and is updated regularly.

What is Cefprozil?

Cefprozil has active ingredients of cefprozil. It is often used in sinusitis. eHealthMe is studying from 1,103 Cefprozil users. Check the latest studies of Cefprozil.

What is Interstitial nephritis?

Interstitial nephritis (inflammation of the kidney) is found to be associated with 1,097 drugs and 1,565 conditions by eHealthMe. Check the latest studies of Interstitial nephritis.

On Jul, 04, 2026

1,051 people reported to have side effects when taking Cefprozil.
Among them, 16 people (1.52%) have Interstitial nephritis.

Could Cefprozil cause Interstitial nephritis?

Among these 16 people:

How long have people been on Cefprozil when they have Interstitial nephritis? *

What is the gender of people who have Interstitial nephritis when taking Cefprozil? *

female: 50 %
male: 50 %

What is the age of people who have Interstitial nephritis when taking Cefprozil? *

What are other drugs people take besides Cefprozil? *

What are other side effects people have besides Interstitial nephritis? *

Chronic Kidney Disease: 15 people, 93.75%
Acute Kidney Failure: 9 people, 56.25%
Nephrogenic Anaemia (anaemia due to kidney disease): 6 people, 37.50%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 3 people, 18.75%
Renal Injury (kidney injury): 2 people, 12.50%
Renal Tubular Necrosis (death of kidney tubules): 2 people, 12.50%
Nephropathy Toxic (damage to kidney due to toxins): 1 person, 6.25%
Nausea (feeling of having an urge to vomit): 1 person, 6.25%
Indigestion: 1 person, 6.25%
Fatigue (feeling of tiredness): 1 person, 6.25%

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 14 people, 87.50%
Infection: 9 people, 56.25%
Pain: 9 people, 56.25%
High Blood Pressure: 8 people, 50.00%
High Blood Cholesterol: 8 people, 50.00%
Oedema (fluid collection in tissue): 5 people, 31.25%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 25.00%
Nausea (feeling of having an urge to vomit): 4 people, 25.00%
Type 2 Diabetes: 4 people, 25.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cefprozil and have Interstitial nephritis?

- Check whether Interstitial nephritis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefprozil:

Cefprozil (1,103 reports)

Browse all side effects of Cefprozil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Interstitial nephritis:

Interstitial nephritis (1,097 drugs)

Browse all the conditions that are associated with Interstitial nephritis:

Interstitial nephritis (1,565 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefprozil (the active ingredients of Cefprozil) and Cefprozil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.